Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$1.66 - $3.67 $7,149 - $15,806
4,307 Added 10.7%
44,546 $78,000
Q4 2022

Feb 13, 2023

BUY
$2.77 - $5.07 $12,002 - $21,968
4,333 Added 12.07%
40,239 $126,000
Q3 2022

Nov 14, 2022

SELL
$4.27 - $6.39 $380 - $568
-89 Reduced 0.25%
35,906 $176,000
Q2 2022

Aug 12, 2022

BUY
$3.28 - $6.21 $2,853 - $5,402
870 Added 2.48%
35,995 $149,000
Q1 2022

May 11, 2022

BUY
$5.23 - $7.82 $1,474 - $2,205
282 Added 0.81%
35,125 $204,000
Q4 2021

Feb 07, 2022

SELL
$7.29 - $10.97 $426,479 - $641,766
-58,502 Reduced 62.67%
34,843 $261,000
Q3 2021

Nov 10, 2021

SELL
$9.01 - $12.01 $336,595 - $448,669
-37,358 Reduced 28.58%
93,345 $841,000
Q2 2021

Aug 05, 2021

SELL
$10.17 - $12.64 $328,104 - $407,791
-32,262 Reduced 19.8%
130,703 $1.57 Million
Q1 2021

May 14, 2021

BUY
$10.88 - $17.05 $1.36 Million - $2.14 Million
125,240 Added 331.98%
162,965 $2.04 Million
Q4 2020

Feb 12, 2021

BUY
$9.23 - $18.18 $155,691 - $306,660
16,868 Added 80.87%
37,725 $589,000
Q3 2020

Nov 13, 2020

BUY
$9.38 - $12.48 $195,638 - $260,295
20,857 New
20,857 $197,000
Q4 2018

Feb 13, 2019

SELL
$9.51 - $16.6 $1.72 Million - $3 Million
-181,009 Closed
0 $0
Q3 2018

Nov 02, 2018

SELL
$13.05 - $19.05 $1.14 Million - $1.66 Million
-87,189 Reduced 32.51%
181,009 $3.07 Million
Q2 2018

Aug 08, 2018

SELL
$13.9 - $19.8 $807,270 - $1.15 Million
-58,077 Reduced 17.8%
268,198 $3.81 Million
Q1 2018

May 03, 2018

SELL
$16.7 - $26.35 $2.39 Million - $3.76 Million
-142,824 Reduced 30.45%
326,275 $6.2 Million
Q4 2017

Feb 02, 2018

BUY
$11.6 - $17.35 $1.46 Million - $2.19 Million
126,121 Added 36.77%
469,099 $7.69 Million
Q3 2017

Nov 01, 2017

BUY
$8.4 - $15.0 $2.88 Million - $5.14 Million
342,978
342,978 $5.15 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $180M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.